Highlights
-
Q4 Group: net sales up 6% to €1,926m and EBITDA up 3% to €261m
-
Q4 Nutrition: 7% organic growth with strong volume growth in both Animal and Human Nutrition
-
Q4 EBITDA: Nutrition up 3%, Performance Materials up 13%
-
Strong Q4 operating cash flow of €313m supported by working capital reduction
-
2015: solid performance with Group net sales of €7,722m and EBITDA up 4% to €1,075m
-
Proposed dividend stable at €1.65 per ordinary share
Key figures and indicators (continuing operations)
| in € million | Q4 2015 | Q4 2014 | % Change | Volume | Price/mix | FX | Other |
| Sales | 1,926 | 1,811 | 6% | 3% | -2% | 4% | 1% |
| Nutrition | 1,264 | 1,124 | 12% | 7% | 0% | 3% | 2% |
| Performance Materials | 601 | 618 | -3% | -1% | -7% | 5% | |
| EBITDA | 261 | 254 | 3% | | | | |
| Nutrition | 206 | 200 | 3% | | | | |
| Performance Materials | 90 | 80 | 13% | | | | |
| ROCE (%) 1 | 7.6% | 8.2% | | | | | |
1 Based on full year
CEO statement
Feike Sijbesma, CEO/Chairman of the DSM Managing Board, commented: "DSM's fourth quarter performance, slightly ahead of expectations, was encouraging. We are particularly pleased with our progress in Nutrition, where both Animal and Human Nutrition delivered strong organic growth. Performance Materials continued to benefit from improved margins. In addition, our focus on cash flow and working capital efficiency contributed to a strong operating cash flow of €313 million.
This good progress in Q4 completes a year in which we achieved solid results. We delivered strong organic growth in Nutrition despite lower vitamin E prices. Cost savings and good margin management helped drive higher margins in Performance Materials, which also benefited from lower input costs. Currencies, while being a mixed bag, had a favorable effect overall despite the strengthening of the Swiss franc.
We expect to make further progress with our growth initiatives in 2016 both in Nutrition and Performance Materials although the macro-economic context remains challenging. These will be underpinned by our group-wide cost and productivity improvement programs as well as our disciplined focus on capital allocation and working capital. We are on track with these initiatives which will help drive improved profitability and return on capital that we target with our Strategy 2018."
Outlook 2016
DSM aims to deliver increased full-year EBITDA and ROCE in line with the targets set out in its Strategy 2018:
Driving Profitable Growth.
Note for editors: for the full text of the press release, see enclosed pdf or click
here>
Contact Information
Additional Information
Today DSM will hold a conference call for
media from 08:00 to 08:30 and a conference call from for
investors and analysts from 09:00 to 10:00. Details on how to access these calls can be found on the DSM website,
www.dsm.com.
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM N.V. via Globenewswire
HUG#1986557